{"filing":{"accession_number":"0001140361-26-023312","cik":"0001021561","ticker":"NUS","company_name":"NU SKIN ENTERPRISES, INC.","form":"8-K","filing_date":"2026-05-29","report_date":null,"primary_document":"ef20075128_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1021561/000114036126023312/ef20075128_8k.htm"},"events":[{"id":8067,"run_id":7082,"accession_number":"0001140361-26-023312","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Nu Skin held its Annual Meeting of Stockholders on May 28, 2026, at which stockholders voted on four proposals: election of nine directors, advisory approval of executive compensation, approval of an Amended and Restated 2024 Omnibus Incentive Plan, and ratification of PricewaterhouseCoopers LLP as auditor. All four proposals passed with substantial majorities.","company_name":"NU SKIN ENTERPRISES, INC.","ticker":"NUS","filing_date":"2026-05-29","form":"8-K","submitted_at":null,"items":[{"id":2633,"accession_number":"0001140361-26-023312","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure reports stockholder approval of an Amended and Restated 2024 Omnibus Incentive Plan, which is a compensatory arrangement affecting directors and officers. The plan increases share authorization by 2,850,000 shares and extends the termination date to May 28, 2036. This is a material executive compensation event requiring 8-K disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:08:15.035017+00:00","company_name":"","ticker":null,"filing_date":""},{"id":2634,"accession_number":"0001140361-26-023312","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder voting results from Nu Skin's Annual Meeting on May 28, 2026. The filing reports the outcomes of four proposals: election of nine directors, advisory approval of executive compensation, approval of an amended omnibus incentive plan, and ratification of PricewaterhouseCoopers LLP as auditor. All proposals passed with substantial majorities. This is material as it confirms governance and compensation decisions affecting the company's leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:08:15.035017+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":2633,"accession_number":"0001140361-26-023312","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The disclosure reports stockholder approval of an Amended and Restated 2024 Omnibus Incentive Plan, which is a compensatory arrangement affecting directors and officers. The plan increases share authorization by 2,850,000 shares and extends the termination date to May 28, 2036. This is a material executive compensation event requiring 8-K disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:08:15.035017+00:00","company_name":"NU SKIN ENTERPRISES, INC.","ticker":"NUS","filing_date":"2026-05-29"},{"id":2634,"accession_number":"0001140361-26-023312","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder voting results from Nu Skin's Annual Meeting on May 28, 2026. The filing reports the outcomes of four proposals: election of nine directors, advisory approval of executive compensation, approval of an amended omnibus incentive plan, and ratification of PricewaterhouseCoopers LLP as auditor. All proposals passed with substantial majorities. This is material as it confirms governance and compensation decisions affecting the company's leadership and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-30T02:08:15.035017+00:00","company_name":"NU SKIN ENTERPRISES, INC.","ticker":"NUS","filing_date":"2026-05-29"}]}